United States · FDA National Drug Code directory
CETIRIZINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61037-479_414fa38e-f7c6-459c-e063-6294a90a5a54
- Product NDC
- 61037-479
- Form
- SOLUTION
- Composition / generic term
- CETIRIZINE HYDROCHLORIDE
- Labeler
- BAJAJ MEDICAL, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230912
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE, PLASTIC (61037-479-02) · 61037-479-02
- 480 mL in 1 BOTTLE, PLASTIC (61037-479-03) · 61037-479-03
- 5 mL in 1 CUP, UNIT-DOSE (61037-479-06) · 61037-479-06
- 5 mL in 1 BOX, UNIT-DOSE (61037-479-12) · 61037-479-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →